Warning! GuruFocus detected
5 Severe warning signs
with INO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Inovio Pharmaceuticals Inc (NAS:INO) Stock News, Headlines & Updates
Inovio Pharmaceuticals Inc Stock News from GuruFocus
- 1
Apr 09, 2025
INOVIO to Present at Upcoming Scientific Conferences
PRNewswire • 8:00am
INOVIO to Present at Upcoming Scientific Conferences | INO Stock News
GuruFocus News • 7:16am
Mar 19, 2025
Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus News • 1:02am
Q4 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:02pm
Mar 18, 2025
INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
PRNewswire • 4:00pm
Inovio Pharmaceuticals Q4 2024 Earnings: EPS of -$0.65 Beats Estimate, Revenue Surges to $0.117 Million
GuruFocus News • 3:31pm
Mar 13, 2025
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
PRNewswire • 6:00pm
Mar 12, 2025
INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
PRNewswire • 12:00pm
Feb 12, 2025
Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
PRNewswire • 8:00am
Feb 11, 2025
Highbridge Capital Management LLC Acquires Significant Stake in Inovio Pharmaceuticals
GuruFocus News • 8:11pm
Feb 10, 2025
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
PRNewswire • 8:00am
Feb 06, 2025
BlackRock, Inc. Expands Stake in Inovio Pharmaceuticals Inc.
GuruFocus News • 6:31pm
Jan 31, 2025
Vanguard Group Inc. Reduces Stake in Inovio Pharmaceuticals Inc.
GuruFocus News • 12:16am
Jan 29, 2025
INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
PRNewswire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news